The realities of SBLC risk transfer

By: Nathan Hummel and Justine Clark 

This is the final article in a four-part series on the regulatory capital treatment of SBLC risk participations.

The first three articles in this series examined the mechanics of SBLC risk participations, the capital treatment available under the advanced approaches, and the types of entities that may qualify as eligible participants. The final question is often the most important: how can a bank implement these structures in a manner that will withstand scrutiny from auditors, regulators, and examiners?

This article reviews the regulatory foundations supporting SBLC risk participations and outlines the practical steps banks can take to document, report and defend the resulting capital treatment.

Basel standards

The Basel Committee on Banking Supervision (“BCBS”) framework under Basel II and III explicitly allows recognition of unfunded credit protection. Basel II’s original text (¶189-201 for standardised, ¶283-287, ¶480-487 for IRB) set out conditions very similar to the US eligible guarantee definition. The concept of double default was introduced by BCBS in 2005, recognising that “the risk of both a borrower and a guarantor defaulting on the same obligation may be substantially lower than the risk of only one of the parties defaulting”. The US implementation of double default (in §217.135) aligns with the Basel approach and was vetted in rulemaking. In fact, in the Federal Register notices around 2007 (Basel II NPR) and 2013 (Basel III final rule), regulators discussed public comments on guarantees and double default. They ultimately removed the limitation of “eligible guarantor” for non-securitisation exposures in advanced approaches to broaden recognition of protection, consistent with the Basel framework’s intention to recognise a wide range of guarantors, provided they are creditworthy (Basel allows corporates with A- or better internal rating under IRB, which the US mirrored before Dodd-Frank removed references to ratings).

The Basel Committee’s publications (e.g., Basel II: International Convergence of Capital Measurement and Capital Standards, June 2006) can be cited as persuasive guidance. They emphasise that for a guarantee to reduce capital, it must be “direct, explicit, irrevocable and unconditional,” which exactly matches our rule. Basel’s rationale is that such guarantees effectively shift risk such that capital can be held against the guarantor’s risk, not the borrower’s. Additionally, the Basel framework (CRE22 and CRE32 in the current Basel consolidated framework) outlines how partial guarantees are handled (proportional approach) and how double default is an exceptional but allowed technique.

By aligning the SBLC participation with these standards, a bank is not doing anything novel or aggressive; it is utilising a well-established risk mitigation technique endorsed by international standards. Indeed, many global banks engage in risk distribution of trade finance exposures (including SBLCs) through unfunded participations to entities like insurance companies or funds to manage capital. The Basel Trade Finance guidance and FAQs also have recognised that when structured properly, such participations/ insurance reduce risk and hence capital – although they caution about legal certainty.

In summary, both US guidance and Basel standards support the permissibility of RWA reduction through genuine risk participations. The bank should, if needed, reference these standards in conversations with auditors or examiners to show this treatment is grounded in widely accepted prudential concepts.

Our recommended best practices a roadmap for defending the use of RWA Reduction in Regulatory Reporting. are set forth below.

US banking law and regulation permit, and indeed encourage, prudent transfer of credit risk to third parties. Selling an unfunded, pro-rata risk participation in an SBLC to a highly rated eligible participant can legitimately reduce a bank’s risk-weighted assets, improving its regulatory capital ratios, so long as the transaction is structured as a true guarantee meeting the regulatory criteria for an “eligible double default guarantor.”

Best practices

To effectively implement and support the RWA benefit from SBLC risk participations, we recommend the following best practices for banks:

●      Transaction structuring: Involve the legal, risk, and accounting teams early when structuring the SBLC participation. Ensure the participation agreement language meets the eligible guarantee criteria (no set-off that dilutes unconditionality, clear payment obligations, lack of recourse to the bank selling the participation for non-payment by the applicant, etc.). Use standard documentation (for example, the BAFT Master Participation Agreement or similar) which is usually crafted to be a true sale of the participation and meet regulatory standards.

●      True sale and enforceability opinion: Consider obtaining a legal opinion confirming that the participation constitutes a true sale/transfer of the credit risk and that the participant’s obligations would be enforceable even in adverse scenarios (e.g., if the bank is in receivership, the FDIC would recognise the participant’s interest; FDICIA protections for participations could be cited). While not required, such opinions give comfort that the risk transfer is effective, underpinning the capital treatment.

●      Due diligence on participant: Since capital relief hinges on the participant’s credit quality, perform due diligence on the participant and, where applicable, the asset manager. Verify it falls under “eligible guarantor” (if needed) and “eligible double default guarantor” criteria. Document the participant’s credit rating (if available) or internal risk assessment. Ideally, the participant should be investment-grade. If the asset manager is a fund, understand the fund’s structure; is it collateralising its obligation, or is there any weakness? The strength of the guarantor is crucial; remember, if the guarantor’s credit deteriorates, the benefit may be moot (and the bank might then allocate capital for counterparty risk accordingly).

●      Internal approval and limits: Treat unfunded participations as a form of credit exposure to the participant. The bank’s credit committee should approve entering into the risk participation arrangement, effectively extending contingent credit to the participant (since the participant could fail to pay when called upon). Set appropriate limits on aggregate exposure to such participants to avoid concentration. This also helps from a regulatory perspective: it shows the bank manages the risk of the guarantor, not just blindly taking capital relief.

●      Accounting and reporting alignment: Coordinate with the accounting team so that financial statement disclosures appropriately reflect the arrangement (e.g., disclose that certain SBLCs are subject to participations – perhaps in the contingent liabilities footnote). This transparency prevents any allegation that the bank hid obligations. And ensure the regulatory reporting (RC-R etc.) is done correctly – e.g., only count the net exposure or do the split in risk weight columns as required. Maintain worksheets that show how the notional amount is divided and which risk weight or PD was applied. These workpapers will be handy during exams.

●      Policy documentation: Update the bank’s capital adequacy policies to explicitly mention that unfunded risk participations are recognised as credit risk mitigation per 12 C.F.R. Part 217. Set forth the conditions under which the bank will rely on such mitigation. For advanced approaches banks, this could be in the section of the policy dealing with credit risk mitigation and double default. For standardised approaches, it could be in the risk weight assignment procedures.

●      Regulator communication: If the strategy is significant (say the bank is doing this on a material portfolio of SBLCs), it may be wise to proactively discuss it with your regulators (Fed/OCC examiners) at a periodic meeting. Not for approval (since it’s already allowed by rule) but to walk them through the program. Explain the rationale: “We have a program to distribute SBLC risk to strong third parties to manage our exposures and capital. We only do so under strict criteria and in compliance with capital rules.” Such communication can preempt misunderstandings and demonstrate the bank’s diligent risk management.

●      Monitoring and contingency: Post-execution, monitor the participant’s financial health. The bank should have an exit strategy or replacement plan if the participant is downgraded below a threshold. For example, the participation agreement might allow the bank to terminate the participation (and perhaps replace it with another) if the participant’s credit rating falls below investment grade – this protects the bank from losing capital relief while still being stuck with a weak guarantor. Also, include the participant in exposure stress testing: what if they default? Normally, that would coincide with the bank having to absorb the exposure again – ensure capital buffers for that unlikely scenario.

●      Pillar 3 disclosure (if applicable): Advanced approaches banks have to publish qualitative disclosures about CRM. Use that section to mention the use of participations. This not only fulfils disclosure requirements but also normalises the practice as part of the bank’s risk management toolkit.

Defence of RWA reduction in regulatory reporting

When reporting the RWA reduction on regulatory filings (e.g., Call Report RC-R, FR Y-9C, or FFIEC 101 for advanced approaches), banks should be prepared to defend the treatment with documentation and references to authority. The defence essentially writes itself from the regulations:

1. Cite the Regulations: The primary defence is citation to 12 C.F.R. §217.36 (for standardised) and 12 C.F.R. §§217.134/135 (for advanced) that explicitly allow recognition of eligible guarantees. For example, 12 C.F.R.§217.36(a)(1) states a bank “may recognize the credit risk mitigation benefits of an eligible guarantee… by substituting the risk weight of the protection provider”. 12 C.F.R 217.134 similarly allows recognition in IRB.12 C.F.R §217.135 provides the double default framework. By showing that the participation meets the “eligible guarantee” definition (document how each criterion is satisfied in a memo or checklist), the bank demonstrates compliance with the rule requirements for capital relief.
2. Show legal agreements: The bank should retain the participation agreement and possibly a legal opinion or analysis confirming that the agreement is enforceable and constitutes a true transfer of credit risk. Key points to highlight: it is unconditional, irrevocable, etc., aligning with regulatory criteria. If there were any material exceptions, the bank should be transparent and have a mitigant (e.g., if the participation has a slight condition, explain why it still meets the spirit or why it’s negligible).
3. Internal approvals and policies: The bank’s internal capital policy should outline how guarantees and participations are treated. Demonstrating that the bank has a consistent framework (approved by risk management or the board) for recognising credit risk mitigation bolsters the case that this is a normal, controlled practice. For advanced approaches banks, indicate that the credit risk mitigation is captured in the PD/LGD assignment process or via an adjustment in the risk systems per the Basel rule. If double default is used, evidence of the supervisory approval of the correlation detection process (as required by 12 C.F.R.§217.135(a) (6)) should be on file.27
4. Call Report instructions and precedent: The bank can reference Call Report instructions (as quoted above), which clearly allow moving participated amounts to lower risk weight categories. This is a powerful defence because it is the official reporting guidance. An examiner or auditor cannot argue with the Call Report rules that specifically contemplate participations (“conveyed” portions) getting different risk weights. For advanced approaches, the FFIEC 101 instructions similarly discuss reporting of hedged exposures and the use of double default if elected.
5. Distinguish GAAP vs regulatory intent: If someone raises the point “but the SBLC is still on your books,” the bank should clarify that regulatory capital is not equivalent to accounting exposure. There are many instances in capital rules where accounting does not dictate capital treatment; for example, derivative netting, recognition of guarantees, or consolidation differences. The bank can point out that the purpose of capital rules is to ensure sufficient capital for actual risk. Here, actual credit risk has been partly laid off to a third party; ignoring that would overstate the bank’s risk. Moreover, the bank still holds capital for the risk of the guarantor defaulting (in the form of substituting the guarantor’s risk weight or PD), so the risk is still capitalised, just in a shifted manner. This argument aligns with the substance-over-form approach of prudential regulation.
6. Consistent application: Ensure the bank is not “cherry-picking.” If it sells participations on multiple SBLCs or loans, it should consistently take the capital relief for all that meet criteria (and not for those that don’t). Consistency shows the bank isn’t using this one-off to game metrics but as part of a broader risk management strategy.
7. Stress testing and concentration: Be prepared to discuss what happens if the guarantor fails. In capital planning (CCAR/DFAST) or internal stress tests, the bank presumably would consider the counterparty risk – i.e., if the participant manager went bankrupt at the same time as the SBLC obligor defaulted, the bank would be on the hook. However, that joint event is precisely what double default accounts for statistically. The bank can mention that it monitors the participant’s financial condition and would take action (like replacing the participant or hedging) if it deteriorated. This helps alleviate any safety and soundness concerns the examiner might have about over-reliance on the guarantee.
8. Regulatory precedents: If any, the bank could point to other banks that use similar structures. Trade finance industry groups have noted that US banks use unfunded participations and have sought clarity on capital treatment. For example, industry comment letters to regulators (during Basel III implementation) supported recognising insurance and participations as risk mitigants. While individual cases are usually confidential, the practice is not unheard of, and no rule forbids it. On the contrary, it’s encouraged to disperse risk.

By assembling a concise analysis memo (which could be an internal version of this series of articles) and keeping it in the credit file or capital adequacy documentation, the bank can readily justify the RWA reduction at each examination or audit. In any regulatory filing (like Pillar 3 disclosures), the bank might also disclose that it uses credit risk mitigation techniques, including participations, to manage risk-weighted assets – adding transparency.

In short, the defence is: we follow the regulations. The capital rules explicitly allow this, and we have done it in accordance with those rules. That is a strong position that should satisfy regulatory scrutiny, especially if all supporting evidence is in order.

Throughout this series, the central theme has been that regulatory capital should reflect economic risk. The framework surrounding SBLC risk participations is built on that principle. For banks willing to invest in the legal, operating, and governance requirements, these structures offer a recognised and defensible mechanism for aligning capital treatment more closely with the underlying distribution of risk.

Download the full whitepaper here. 

Disclaimer: This material does not constitute legal advice or an opinion of Moses & Singer LLP or any member of the firm.  It does not create or invite an attorney-client relationship and may be rendered incorrect by future developments.  It is recommended that it not be relied upon in connection with any dispute or other matter but that professional advice be sought.

Attorney Advertising: Under the laws, rules or regulations of certain jurisdictions, this material may be construed as an advertisement or solicitation.

Copyright © 2026 Moses & Singer LLP.  All rights reserved.